Monthly Archives: November 2018

Large study of trans people in the Netherlands shows growing numbers seeking treatment, low regret rates

Medical transition by trans people, its prevalence and demographics, and rates of regret of treatment are perennial subjects of public curiosity and media controversy. With unfortunate frequency, this has taken the form of scaremongering that depicts the growing numbers of … Continue reading

Posted in Outcomes of transition, Regret and detransition, Statistics and demographics, Transgender medicine | Tagged , , | Leave a comment

Transgender depersonalization testimonies around the web, 2018

Previously: Depersonalization in gender dysphoria: widespread and widely unrecognized Throughout numerous articles, I’ve covered many aspects of the experience of chronic depersonalization among trans people, a condition of persistent feelings of unreality or having “no self” that’s especially common in … Continue reading

Posted in Depersonalization, Gender dysphoria, Psychology and psychiatry | Tagged , , | Leave a comment

Bad trip: What trans people should know about cannabis and depersonalization

Previously: Depersonalization in gender dysphoria: widespread and widely unrecognized Substance abuse is highly prevalent in the transgender population, and is known to be associated with psychosocial risk factors such as stigma, discrmination, and trauma (Glynn & van den Berg, 2017). … Continue reading

Posted in Depersonalization, Health care, Psychology and psychiatry, Sociological research | Tagged , , | Leave a comment

Update on case reports: Cyproterone acetate and meningioma in trans women

Previously: Cyproterone acetate and meningioma risk in trans women (March 2018) Disclaimer: I am not a doctor, and this is not medical advice. Do not take any medication without appropriate medical supervision. Summary Cyproterone acetate (CPA) is commonly used as … Continue reading

Posted in Endocrinology, Oncology, Progestogens, Transgender medicine | Tagged , , | 1 Comment